Why context matters in health testing: beyond the “self-test” kit Whether you’re checking your thyroid levels, vitamin deficiencies, or hormone balance, what direct-to-consumer “tests” don’t tell you ...

This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...

This report, The changing nature of diagnosis, sets out the implications for practitioners and patients of the technological ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn had the opportunity to comment for radio coverage of the ...

A consultation by the UK Medicines and Healthcare products Regulatory Agency indicates a new direction for public and patient involvement.

Our summary of, and thoughts on, the recently published WHO principles for human genome data collection, access, use and sharing.

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

A set of consensus statements on the use of biomarkers in cancer research and treatment were released this month. We discuss what these mean.

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...